Overview

Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
A Multi-center study to determine effects of various doses of Macroflux Parathryroid Hormone (PTH) in women with osteoporosis
Phase:
Phase 2
Details
Lead Sponsor:
Zosano Pharma Corporation
Zosano Pharma Inc.
Treatments:
Teriparatide